LITAK 10 mg/5 ml
Description: LITAK is a clear, colourless solution for injection. It is a cytostatic agent, an antineoplastic (chemotherapy agent), and an immunosuppressive substance that belongs to the group of purine nucleoside analogues. It works by interfering with the production of new DNA in cells like malignant white blood cells.
Share Now
Additional Information
Active Ingredient: Cladribine
Description: LITAK is a clear, colourless solution for injection. It is a cytostatic agent, an antineoplastic (chemotherapy agent), and an immunosuppressive substance that belongs to the group of purine nucleoside analogues. It works by interfering with the production of new DNA in cells like malignant white blood cells.
Indication: Litak is a solution for injection containing cladribine, indicated for the treatment of rare forms of leukemia or lymphoma.
Strength: 10 mg of Cladribine in 5 ml of solution (2 mg/ml)
Business Partner: Lipomed
Origin: Switzerland
Related Products
Related products
Disclaimer
Pharma Solutions is the master distributor for the listed products in Egypt. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.




